| D007559 |
Ivermectin |
A mixture of mostly avermectin H2B1a (RN 71827-03-7) with some avermectin H2B1b (RN 70209-81-3), which are macrolides from STREPTOMYCES avermitilis. It binds glutamate-gated chloride channel to cause increased permeability and hyperpolarization of nerve and muscle cells. It also interacts with other CHLORIDE CHANNELS. It is a broad spectrum antiparasitic that is active against microfilariae of ONCHOCERCA VOLVULUS but not the adult form. |
Eqvalan,Ivomec,MK-933,Mectizan,Stromectol,MK 933,MK933 |
|
| D007783 |
Lactones |
Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES. |
Lactone |
|
| D008297 |
Male |
|
Males |
|
| D010270 |
Parasite Egg Count |
Determination of parasite eggs in feces. |
Count, Parasite Egg,Counts, Parasite Egg,Egg Count, Parasite,Egg Counts, Parasite,Parasite Egg Counts |
|
| D011716 |
Pyrantel Pamoate |
Broad spectrum antinematodal anthelmintic used also in veterinary medicine. |
Pyrantel Embonate,Antiminth,Combantrin,Embovin,Embonate, Pyrantel,Pamoate, Pyrantel |
|
| D002159 |
Cambendazole |
A nematocide effective against a variety of gastrointestinal parasites in cattle, sheep, and horses. |
5-Isopropoxycarbonylamino-2-(4-thiazoyl)benzimidazole,Noviben |
|
| D002986 |
Clinical Trials as Topic |
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. |
Clinical Trial as Topic |
|
| D004351 |
Drug Resistance |
Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. |
Resistance, Drug |
|
| D005260 |
Female |
|
Females |
|
| D005860 |
Germany, West |
The former Federal Republic of Germany which was reunified with the former German Democratic Republic in 1990. |
Federal Republic of Germany,Germany, Federal Republic of |
|